Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT00664066
Eligibility Criteria:
Inclusion Criteria:
* Adult patients must have established Chronic Kidney Disease (CKD) and be willing and able to provide written informed consent.
* Patients must already be receiving DYNEPO treatment at time of study entry.
* Patients who are likely to receive DYNEPO for at least 1 year.
Exclusion Criteria:
* Known intolerance to EPO of any of its excipients
* Known of suspected Pure Red Cell Aplasia (PRCA)
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00664066
Study Brief:
Protocol Section:
NCT00664066